VMP 42032511000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Aprepitant 80mg capsules
BNF code 0406000ADAAAAAA
Virtual Therapeutic Moiety Aprepitant
Date identifier became valid 7 Jul 2023
Previous product identifier 409208006
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 6 Jan 2005
Previous name Aprepitant 80mg capsules
Basis of previous name Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units capsule
Unit dose unit of measure capsule
Virtual Product Ingredient
Ingredient Aprepitant
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 80.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route capsule.oral
Dose Form
Formulation Oral capsule
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Aprepitant 80mg capsules (A A H Pharmaceuticals Ltd)
Aprepitant 80mg capsules (Accord-UK Ltd)
Aprepitant 80mg capsules (Martindale Pharmaceuticals Ltd)
Aprepitant 80mg capsules (Zentiva Pharma UK Ltd)
Emend 80mg capsules (Merck Sharp & Dohme (UK) Ltd)
Virtual Medicinal Product Packs
Aprepitant 80mg capsules 2 capsule

dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.

Feedback